Pages that link to "Q33320536"
The following pages link to Recombination-mediated genetic engineering of a bacterial artificial chromosome clone of modified vaccinia virus Ankara (MVA). (Q33320536):
Displaying 50 items.
- Human cytomegalovirus vaccine based on the envelope gH/gL pentamer complex (Q21089588) (← links)
- A candidate HIV/AIDS vaccine (MVA-B) lacking vaccinia virus gene C6L enhances memory HIV-1-specific T-cell responses (Q21135240) (← links)
- Back to BAC: the use of infectious clone technologies for viral mutagenesis (Q26859104) (← links)
- Viral bacterial artificial chromosomes: generation, mutagenesis, and removal of mini-F sequences (Q26860414) (← links)
- The evolution of poxvirus vaccines (Q26995905) (← links)
- Deletion of the vaccinia virus gene A46R, encoding for an inhibitor of TLR signalling, is an effective approach to enhance the immunogenicity in mice of the HIV/AIDS vaccine candidate NYVAC-C (Q27306437) (← links)
- Immunogenic profiling in mice of a HIV/AIDS vaccine candidate (MVA-B) expressing four HIV-1 antigens and potentiation by specific gene deletions (Q27320923) (← links)
- Modified Vaccinia Virus Ankara (Q28223836) (← links)
- Generation of a complete single-gene knockout bacterial artificial chromosome library of cowpox virus and identification of its essential genes (Q28659589) (← links)
- Expression and cellular immunogenicity of a transgenic antigen driven by endogenous poxviral early promoters at their authentic loci in MVA (Q28727937) (← links)
- Candidate influenza vaccines based on recombinant modified vaccinia virus Ankara. (Q30375979) (← links)
- A method for the generation of ectromelia virus (ECTV) recombinants: in vivo analysis of ECTV vCD30 deletion mutants (Q33429965) (← links)
- Red-mediated transposition and final release of the mini-F vector of a cloned infectious herpesvirus genome (Q33517637) (← links)
- Immediate-early expression of a recombinant antigen by modified vaccinia virus ankara breaks the immunodominance of strong vector-specific B8R antigen in acute and memory CD8 T-cell responses (Q34055541) (← links)
- Improving the MVA vaccine potential by deleting the viral gene coding for the IL-18 binding protein (Q34182371) (← links)
- Drug resistance of clinical varicella-zoster virus strains confirmed by recombinant thymidine kinase expression and by targeted resistance mutagenesis of a cloned wild-type isolate (Q34464333) (← links)
- Deletion of the viral anti-apoptotic gene F1L in the HIV/AIDS vaccine candidate MVA-C enhances immune responses against HIV-1 antigens (Q34465228) (← links)
- Immunogenicity and efficacy of a chimpanzee adenovirus-vectored Rift Valley fever vaccine in mice (Q34529382) (← links)
- Improving Adaptive and Memory Immune Responses of an HIV/AIDS Vaccine Candidate MVA-B by Deletion of Vaccinia Virus Genes (C6L and K7R) Blocking Interferon Signaling Pathways (Q34796206) (← links)
- Virological and immunological characterization of novel NYVAC-based HIV/AIDS vaccine candidates expressing clade C trimeric soluble gp140(ZM96) and Gag(ZM96)-Pol-Nef(CN54) as virus-like particles. (Q34991112) (← links)
- The relative magnitude of transgene-specific adaptive immune responses induced by human and chimpanzee adenovirus vectors differs between laboratory animals and a target species (Q35091556) (← links)
- Investigation of IRES Insertion into the Genome of Recombinant MVA as a Translation Enhancer in the Context of Transcript Decapping (Q35642108) (← links)
- Deletion of Fifteen Open Reading Frames from Modified Vaccinia Virus Ankara Fails to Improve Immunogenicity (Q35656345) (← links)
- Selection of recombinant MVA by rescue of the essential D4R gene (Q35800430) (← links)
- Removal of vaccinia virus genes that block interferon type I and II pathways improves adaptive and memory responses of the HIV/AIDS vaccine candidate NYVAC-C in mice (Q35943846) (← links)
- Differential immunogenicity between HAdV-5 and chimpanzee adenovirus vector ChAdOx1 is independent of fiber and penton RGD loop sequences in mice (Q36291682) (← links)
- Deletion of specific immune-modulatory genes from modified vaccinia virus Ankara-based HIV vaccines engenders improved immunogenicity in rhesus macaques (Q36397581) (← links)
- Antigenic mapping of an H9N2 avian influenza virus reveals two discrete antigenic sites and a novel mechanism of immune escape (Q36438526) (← links)
- A vaccine based on the rhesus cytomegalovirus UL128 complex induces broadly neutralizing antibodies in rhesus macaques. (Q36559845) (← links)
- Interleukin-1β receptor expressed by modified vaccinia virus Ankara interferes with interleukin-1β activity produced in various virus-infected antigen-presenting cells (Q36741144) (← links)
- Deletion of A44L, A46R and C12L Vaccinia Virus Genes from the MVA Genome Improved the Vector Immunogenicity by Modifying the Innate Immune Response Generating Enhanced and Optimized Specific T-Cell Responses. (Q36947039) (← links)
- Enhancing poxvirus vectors vaccine immunogenicity. (Q36978452) (← links)
- Vaccinia virus protein K7 is a virulence factor that alters the acute immune response to infection (Q37006800) (← links)
- Reflections on the early development of poxvirus vectors (Q37126266) (← links)
- Vaccinia virus vaccines: past, present and future (Q37343595) (← links)
- Deletion of the vaccinia virus N2L gene encoding an inhibitor of IRF3 improves the immunogenicity of modified vaccinia virus Ankara expressing HIV-1 antigens. (Q37643731) (← links)
- Viruses as vaccine vectors for infectious diseases and cancer (Q37646066) (← links)
- Utilizing poxviral vectored vaccines for antibody induction-progress and prospects (Q38112854) (← links)
- Clinical applications of attenuated MVA poxvirus strain. (Q38156198) (← links)
- Use of functional genomics to understand replication deficient poxvirus-host interactions (Q38620980) (← links)
- Enhancing cellular immunogenicity of MVA-vectored vaccines by utilizing the F11L endogenous promoter (Q38937549) (← links)
- ChAdOx1 and MVA based vaccine candidates against MERS-CoV elicit neutralising antibodies and cellular immune responses in mice (Q40173497) (← links)
- Deletion of virulence associated genes from attenuated African swine fever virus isolate OUR T88/3 decreases its ability to protect against challenge with virulent virus (Q40245829) (← links)
- Exploiting 2A Peptides to Elicit Potent Neutralizing Antibodies by a Multi-Subunit Herpesvirus Glycoprotein Complex (Q41921854) (← links)
- Recovery of infectious virus from full-length cowpox virus (CPXV) DNA cloned as a bacterial artificial chromosome (BAC). (Q42266562) (← links)
- Deletion of immunomodulator C6 from vaccinia virus strain Western Reserve enhances virus immunogenicity and vaccine efficacy (Q42280143) (← links)
- Long-term thermostabilization of live poxviral and adenoviral vaccine vectors at supraphysiological temperatures in carbohydrate glass (Q43108138) (← links)
- Generation of an Attenuated Tiantan Vaccinia Virus Strain by Deletion of Multiple Genes (Q45324442) (← links)
- Hazard Characterization of Modified Vaccinia Virus Ankara Vector: What Are the Knowledge Gaps? (Q45325213) (← links)
- Cowpox virus serpin CrmA is necessary but not sufficient for the red pock phenotype on chicken chorioallantoic membranes (Q45362276) (← links)